Skip to main content

JAMA Archives

Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk

Jun. 20, 2022—Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.

Read more


Study finds sexual minority communities disproportionately engage in behaviors to reduce medication costs

Jan. 6, 2022—Vanderbilt research finds that individuals from sexual minority populations, including members of the lesbian, gay, bisexual and queer communities, are more likely than heterosexual individuals to engage in behaviors to reduce medication costs.

Read more


Study finds sexual minority communities disproportionately engage in behaviors to reduce medication costs

Dec. 29, 2021—People from sexual minority populations, including members of the lesbian, gay, bisexual and queer communities, are more likely than heterosexual people to engage in behaviors to reduce medication costs.

Read more


Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

Dec. 21, 2021—  by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...

Read more


Study finds similar success rates with two devices for breathing tube placement

Dec. 15, 2021—Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.

Read more


Study shows continuous glucose monitors improve management of type 2 diabetes

Jul. 15, 2021—For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.

Read more


Strength training for osteoarthritis

Mar. 18, 2021—High-intensity strength training is not more effective than low-intensity training or educational efforts for reducing knee pain in patients with osteoarthritis.

Read more


Study shows drastic increases in opioid-affected births

Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.

Read more


JAMA Health Forum to become full-fledged journal in 2021

Dec. 3, 2020—Just a year after its founding as an online channel of information, the Journal of the American Medical Association’s (JAMA’s) Health Forum will become a full-fledged journal in January 2021.

Read more


Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Nov. 9, 2020—Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

Read more


Study finds COVID-19 antibodies drop substantially in the weeks following infection

Sep. 17, 2020—The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

Read more


Study examines prostate cancer treatment decisions

Jan. 23, 2020—A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more